Its interaction with the digestive system is part of why semaglutide is effective for weight loss
Because the dose starts conservatively, most patients do not experience maximum weight loss effects until they reach the target dose of 2.4 mg per week, which typically happens around month 4 to 5
Pancreatitis and pancreatic cancer Despite the current guidelines against individuals with a history of pancreatic cancer or pre-existing pancreatic conditions, theres no strong evidence that semaglutide, or other GLP-1 medications, increases the risk of pancreatitis, pancreatic cancer or other pancreas-related conditions
Thats why we offer semaglutide GLP-1 as part of our comprehensive approach to helping patients achieve successful weight loss
Whether its navigating the side effects of Wegovy, providing instructions on how to use the pens, how much you could expect to lose, or tips on improving the medications efficacy, we have you covered
Wegovys use for weight loss has already caused issues with availability for diabetes patients and the cost of the drug is also potentially prohibitive
